FDA Inspection 952506 — NVE Pharmaceuticals, Inc.
The FDA completed an inspection of NVE Pharmaceuticals, Inc. on December 16, 2015 in Andover, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 16, 2015
- Fiscal Year
- 2016
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Andover, NJ (United States)